Announcements Trials

Browse Landscape

Status

Completed 3 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 13 Stomach Neoplasms 12 Colorectal Neoplasms 8 Breast Neoplasms 8 Esophageal Neoplasms 7 Rectal Neoplasms 6 Lung Neoplasms 6 Carcinoma, Hepatocellular 6 Glioblastoma 5 Brain Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Colonic Neoplasms 4 Cholangiocarcinoma 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Lymphatic Metastasis 3 Glioma 3 Endometrial Neoplasms 3 Disease 3 Astrocytoma 3 Thyroid Neoplasms 2 Recurrence 2 Pain, Postoperative 2 Oropharyngeal Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Gastrointestinal Stromal Tumors 2

Interventions

aldesleukin 9 Sunitinib 5 Interferon-alpha 4 Chemotherapy, Adjuvant 4 pembrolizumab 3 Vincristine 3 Neoadjuvant Therapy 3 Dactinomycin 3 Cyclophosphamide 3 Bevacizumab 3 sargramostim 2 fludarabine phosphate 2 Robotic Surgical Procedures 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Laparoscopy 2 Gene Expression Profiling 2 Fluorouracil 2 Etoposide 2 Electroporation 2 Doxorubicin 2 Carboplatin 2 Blood Specimen Collection 2 Amplified Fragment Length Polymorphism Analysis 2 tremelimumab 1 toripalimab 1 temsirolimus 1 spartalizumab 1 pazopanib 1 orantinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Kidney Neoplasms × Surgical Procedures, Operative × Clear all

NCT04946266 2022-01-05

MFI2-PREDICT

University Hospital, Strasbourg, France

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡